Immunotherapies to prevent mother-to-child transmission of HIV

about

A phase I randomized clinical trial of candidate human immunodeficiency virus type 1 vaccine MVA.HIVA administered to Gambian infants

P2860

Q35036289-3DDA417E-7F74-4909-848A-842EE6C2AD45

P2860

Immunotherapies to prevent mother-to-child transmission of HIV

Item

http://www.wikidata.org/entity/Q37316629

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Immunotherapies to prevent mother-to-child transmission of HIV

@en

Immunotherapies to prevent mother-to-child transmission of HIV.

@nl

type

Item

label

Immunotherapies to prevent mother-to-child transmission of HIV

@en

Immunotherapies to prevent mother-to-child transmission of HIV.

@nl

prefLabel

Immunotherapies to prevent mother-to-child transmission of HIV

@en

Immunotherapies to prevent mother-to-child transmission of HIV.

@nl

P1476

Immunotherapies to prevent mother-to-child transmission of HIV

@en

P2093

Mark D Hicar

http://www.w3.org/2001/XMLSchema#string

P2860

Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection

HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

Targeting early infection to prevent HIV-1 mucosal transmission.

Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women.

P304

137-143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1570162X11311020006

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23432489

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

HIV transmission

P932

3830960

http://www.w3.org/2001/XMLSchema#string

Immunotherapies to prevent mother-to-child transmission of HIV

about

P2860

P2860

Immunotherapies to prevent mother-to-child transmission of HIV

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932